BioVie (BIVI) announced the pricing of a registered direct offering of 2.667M shares of its common stock priced at-the-market under Nasdaq rules at a price of $2.25 per share, resulting in total gross proceeds of $6M, before deducting the placement agent’s fees and offering expenses. The company also agreed to issue to the investors unregistered warrants to purchase up to 2.667M shares of common stock in a concurrent private placement. The company intends to use the net proceeds from the offering primarily for working capital and general corporate purposes. All of the shares of common stock and associated warrants are being offered by the company. The registered direct offering and concurrent private placement are expected to close on or about October 24. ThinkEquity is acting as sole placement agent for the offering.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on BIVI:
- BioVie Secures $6.66 Million Through Direct Offering
- BioVie Announces Stock Offering and Private Placement
- 3 Penny Stocks to Watch Now, 10/22/24
- BioVie 4.443M share registered direct offering priced at $1.50
- BioVie receives notice of allowance for Japan patent application
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
